Idiopathic pulmonary fibrosis trials in Poland

In Poland 13 Also abroad 111

13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Where
Bialystok, Cracow, Lodz, Poznan, Rzeszów, Warsaw
Age
18 years and over
People
139 worldwide
Run by
AstraZeneca AB
See details and how to join2025-525016-41-00 · EU 2025-525016-41-00
Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Where
Bialystok, Bydgoszcz, Sosnowiec, Świdnik
Age
40 years and over
People
324 worldwide
Run by
Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00
Phase 2Taking people
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Where
Gdansk, Lodz
Age
18 years and over
People
340 worldwide
Run by
Avalyn Pharma Inc.
See details and how to joinNCT06951217
Phase 2Not yet taking people in Poland
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
Where
Bydgoszcz, Lodz, Lublin, Olsztyn
Age
18 years and over
People
112 worldwide
Run by
Agomab Spain S.L.U.
See details and how to join2026-526404-71-00 · EU 2026-526404-71-00
Phase 2Taking people
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Where
Lodz, Łódź, Nowa Sol, Rzeszów, Sosnowiec, Warsaw
Age
40 years and over
People
120 worldwide
Run by
Rein Therapeutics
See details and how to joinNCT06968845 · EU 2025-520715-13-00
Phase 3Not yet taking people in Poland
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Where
Bialystok, Bydgoszcz, Gdansk, Lodz, Olsztyn
Age
18 years and over
People
2,380 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00
Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Where
Bialystok, Krakow, Lodz, Poznan, Rzeszów, Warsaw
Age
40 years and over
People
359 worldwide
Run by
AstraZeneca
See details and how to joinNCT07652658
Phase 3Taking people
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Where
Katowice, Sosnowiec, Szczecin, Warsaw
Age
40 years and over
People
1,100 worldwide
Run by
PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00
Phase 2Taking people
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Where
Katowice, Lodz, Szczecin, Warsaw
Age
40 years and over
People
240 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07516951 · EU 2024-514246-37-00
Phase 2Taking people
An Open-Label Extension Study of Subjects who Received an Avalyn Inhaled Antifibrotic Agent
Where
Bydgoszcz, Gdansk, Katowice, Lodz
Age
18 years and over
People
128 worldwide
Run by
Avalyn Pharma Inc.
See details and how to join2024-518289-28-00 · EU 2024-518289-28-00
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
Where
Bialystok, Bydgoszcz, Gdansk, Katowice, Lodz, Olsztyn
Age
18 years and over
People
239 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 · EU 2023-503697-21-01
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
Where
Bialystok, Bydgoszcz, Gdansk, Katowice, Lodz, Olsztyn
Age
18 years and over
People
249 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 · EU 2023-503699-25-00
Phase 2Taking people
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Where
Bydgoszcz, Sosnowiec, Warsaw
Age
40 years and over
People
165 worldwide
Run by
AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00